Multimodal Imaging Evaluation and Prognostic Analysis of Cardiac Allograft Vasculopathy in Heart Transplantation

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorXie Mingxing

About this trial

The aim is to (1) establish a system of multimodal imaging technology; (2) jointly apply multimodal imaging technology to diagnose of cardiac allograft vasculopathy of heart transplantation; (3) construct a multimodal imaging technology prediction model of adverse events, screening the best non-invasive imaging prediction indicators.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

1,000 Participants
are grouped into 4 trial groups

Locations

This trial has no locations

Sponsors and collaborators

Xie Mingxing

Lead sponsor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Sponsor institution

Second Affiliated Hospital, School of Medicine, Zhejiang University

Collaborator

Shanghai Zhongshan Hospital

Collaborator

Henan Provincial People's Hospital

Collaborator

Wuhan Asia Heart Hospital

Collaborator

Guangdong Provincial People's Hospital

Collaborator